Amdocs Limited (DOX) Income Statement
DOX FY2025 at a glance
Fiscal year ended September 30, 2025 · U.S. dollarsDOX revenue and net income
Where DOX's revenue goes
FY2025Each bar shows an amount and its share of revenue. DOX kept 12.5% of revenue as net income.
DOX profit margins
DOX growth rates
to FY2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −9.4% | −0.3% | +1.7% | +2.2% |
| Gross profit | −5.5% | +0.8% | +3.2% | +2.5% |
| Operating income | +31.0% | +7.4% | +6.7% | +4.8% |
| Net income | +14.5% | +0.9% | +2.6% | +2.4% |
| EPS (diluted) | +8.5% | +9.7% | +9.5% | +7.5% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
DOX quarterly EPS vs estimates
Amdocs beat the analyst EPS estimate in 8 of the last 8 quarters. Next report: November 10, 2026 (estimate $1.78).
DOX income statement
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.53B | $5.00B | $4.89B | $4.58B | $4.29B | $4.17B | $4.09B | $3.97B | $3.87B | $3.72B |
| Cost of revenue | $2.87B | $3.25B | $3.16B | $2.96B | $2.81B | $2.76B | $2.65B | $2.60B | $2.51B | $2.41B |
| Gross profit | $1.66B | $1.76B | $1.73B | $1.62B | $1.48B | $1.41B | $1.43B | $1.38B | $1.36B | $1.31B |
| Research & development | $340.8M | $360.8M | $374.9M | $354.7M | $312.9M | $282.0M | $273.9M | $276.6M | $259.1M | $252.3M |
| Sales, general & admin | $506.1M | $572.8M | $570.7M | $528.6M | $487.3M | $458.5M | $492.5M | $481.1M | $472.8M | $464.9M |
| Total operating expenses | $834.7M | $1.13B | $1.07B | $954.4M | $879.0M | $818.7M | $863.8M | $866.2M | $842.2M | $827.0M |
| Operating income | $823.4M | $628.6M | $654.0M | $664.8M | $598.7M | $594.8M | $569.7M | $428.3M | $517.3M | $483.1M |
| Interest income | $9.2M | $17.5M | $21.2M | $7.8M | $4.8M | $4.2M | $6.2M | $6.6M | $8.0M | $6.8M |
| Interest expense | $42.4M | $34.9M | $23.1M | $16.9M | $21.3M | $10.4M | $3.9M | $2.8M | $1.6M | $1.7M |
| Income before taxes | $693.2M | $591.1M | $636.4M | $648.4M | $814.3M | $583.3M | $567.9M | $421.5M | $512.9M | $484.7M |
| Income taxes | $125.5M | $94.8M | $93.4M | $98.9M | $125.9M | $85.5M | $88.4M | $67.1M | $76.1M | $75.4M |
| Net income | $564.7M | $493.2M | $540.7M | $549.5M | $688.4M | $497.8M | $479.4M | $354.4M | $436.8M | $409.3M |
| EBITDA | $927.1M | $819.0M | $855.2M | $889.9M | $1.04B | $792.2M | $777.6M | $635.5M | $729.4M | $698.2M |
| EPS (diluted) | $6.99 | $6.44 | $5.91 | $5.30 | $4.80 | $4.44 | $4.31 | $4.03 | $3.80 | $3.57 |
| Gross margin | 36.6% | 35.1% | 35.3% | 35.4% | 34.5% | 33.9% | 35.1% | 34.7% | 35.2% | 35.2% |
| Operating margin | 18.2% | 12.6% | 13.4% | 14.5% | 14.0% | 14.3% | 13.9% | 10.8% | 13.4% | 13.0% |
| Net margin | 12.5% | 9.9% | 11.1% | 12.0% | 16.1% | 11.9% | 11.7% | 8.9% | 11.3% | 11.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.17B | $1.17B | $1.16B | $1.15B | $1.14B | $1.13B | $1.11B | $1.26B | $1.25B | $1.25B | $1.25B | $1.24B |
| Cost of revenue | $707.7M | $737.9M | $727.7M | $720.2M | $711.1M | $698.0M | $682.3M | $824.9M | $810.0M | $802.0M | $812.7M | $803.6M |
| Gross profit | $467.2M | $434.1M | $428.2M | $430.0M | $433.3M | $430.2M | $427.8M | $439.0M | $440.1M | $443.9M | $432.5M | $439.0M |
| Research & development | $86.4M | $87.0M | $82.0M | $87.9M | $86.9M | $81.8M | $84.3M | $90.1M | $90.4M | $91.2M | $89.2M | $97.7M |
| Sales, general & admin | $149.3M | $153.7M | $113.7M | $121.8M | $127.6M | $134.6M | $122.1M | $138.7M | $144.0M | $147.6M | $142.5M | $140.4M |
| Total operating expenses | $256.2M | $241.5M | $221.5M | $224.3M | $230.8M | $232.4M | $229.0M | $326.3M | $264.2M | $288.1M | $248.1M | $300.0M |
| Operating income | $211.0M | $192.5M | $206.7M | $205.7M | $202.5M | $197.7M | $198.8M | $112.7M | $175.9M | $155.7M | $184.3M | $138.9M |
| Interest expense | $14.1M | $6.0M | $11.3M | $11.8M | $11.7M | $8.5M | $6.4M | $9.2M | $6.9M | $11.7M | $9.8M | $5.3M |
| Income before taxes | $90.5M | $176.9M | $195.4M | $120.8M | $190.8M | $189.3M | $192.4M | $103.4M | $169.0M | $144.1M | $174.6M | $133.6M |
| Income taxes | $27.3M | $38.1M | $37.0M | $23.7M | $36.0M | $25.3M | $40.6M | $16.3M | $28.0M | $24.7M | $25.8M | $31.0M |
| Net income | $62.2M | $137.8M | $157.6M | $97.1M | $154.0M | $163.2M | $151.1M | $86.4M | $140.3M | $118.5M | $148.0M | $102.0M |
| EBITDA | $157.0M | $235.9M | $268.7M | $185.6M | $252.1M | $244.1M | $245.2M | $111.5M | $221.8M | $207.7M | $230.2M | $167.1M |
| EPS (diluted) | $1.68 | $1.78 | $1.81 | $1.83 | $1.72 | $1.78 | $1.66 | $1.70 | $1.62 | $1.56 | $1.56 | $1.42 |
| Gross margin | 39.8% | 37.0% | 37.0% | 37.4% | 37.9% | 38.1% | 38.5% | 34.7% | 35.2% | 35.6% | 34.7% | 35.3% |
| Operating margin | 18.0% | 16.4% | 17.9% | 17.9% | 17.7% | 17.5% | 17.9% | 8.9% | 14.1% | 12.5% | 14.8% | 11.2% |
| Net margin | 5.3% | 11.8% | 13.6% | 8.4% | 13.5% | 14.5% | 13.6% | 6.8% | 11.2% | 9.5% | 11.9% | 8.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in DOX's financial statements (latest annual report filed December 15, 2025); data from EODHD. Sales, general & administrative expenses include sales and marketing.
DOX financial results
In fiscal year 2025 (ended September 30, 2025), Amdocs reported revenue of $4.5 billion, down 9.4% from the year before. It had net income of $564.7 million (up 14.5%), a net profit margin of 12.5%. Diluted earnings per share came to $6.99. Over five years revenue grew at an average rate of 1.7% a year.
See the DOX stock overview for the latest quote and news, or the DOX chart for price history and technical indicators.
DOX income statement FAQ
What is Amdocs's annual revenue?
Amdocs reported total revenue of $4.5 billion for fiscal year 2025, which ended on September 30, 2025. That was down 9.4% from $5.0 billion the previous year.
Is Amdocs profitable?
Yes. Amdocs reported net income of $564.7 million in fiscal 2025, a net profit margin of 12.5%; its operating margin was 18.2%.
What is Amdocs's gross margin?
Amdocs's gross margin was 36.6% in fiscal 2025: for every $100 of revenue, Amdocs kept $37 after the direct cost of its products and services.
How much does Amdocs spend on research and development?
Amdocs spent $340.8 million on research and development in fiscal 2025, 7.5% of revenue.
How fast is Amdocs growing?
Revenue grew 1.7% a year on average over the last five fiscal years, from $4.2 billion to $4.5 billion.
What are Amdocs's earnings per share?
Amdocs earned $6.99 per diluted share in fiscal 2025, compared with $6.44 a year earlier.
When will Amdocs report its next earnings?
Amdocs is expected to report results for the quarter ending September 30, 2026 on November 10, 2026 after the market closes.
When does Amdocs's fiscal year end?
Amdocs's fiscal year ends in September. The latest annual report covers the year ended September 30, 2025 and was filed on December 15, 2025.